SVRA logo

SVRA
Savara Inc

22,676
Mkt Cap
$1.09B
Volume
2.11M
52W High
$5.49
52W Low
$1.89
PE Ratio
-10.02
SVRA Fundamentals
Price
$6.31
Prev Close
$5.36
Open
$5.35
50D MA
$3.98
Beta
0.95
Avg. Volume
1.53M
EPS (Annual)
-$0.4838
P/B
9.82
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Savara (NASDAQ:SVRA) Hits New 12-Month High - Here's What Happened
Savara (NASDAQ:SVRA) Sets New 12-Month High - Time to Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Savara Inc. (NASDAQ:SVRA) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Savara Inc. (NASDAQ:SVRA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten brokerages that are covering the stock, MarketBeat Ratings reports. One...
MarketBeat·6d ago
News Placeholder
Savara Announces Participation in Upcoming Investor Healthcare Conferences
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host one on one meetings...
Business Wire·8d ago
News Placeholder
Savara (NASDAQ:SVRA) Shares Up 7.3% - Still a Buy?
Savara (NASDAQ:SVRA) Stock Price Up 7.3% - Still a Buy...
MarketBeat·8d ago
News Placeholder
HC Wainwright Has Positive Outlook of Savara FY2029 Earnings
Savara Inc. (NASDAQ:SVRA - Free Report) - Stock analysts at HC Wainwright increased their FY2029 earnings per share estimates for Savara in a research note issued on Thursday, November 13th. HC...
MarketBeat·10d ago
News Placeholder
Lifesci Capital Analysts Raise Earnings Estimates for Savara
Savara Inc. (NASDAQ:SVRA - Free Report) - Equities researchers at Lifesci Capital upped their FY2025 earnings estimates for Savara in a note issued to investors on Thursday, November 13th. Lifesci...
MarketBeat·11d ago
News Placeholder
Savara (NASDAQ:SVRA) Stock Price Expected to Rise, Oppenheimer Analyst Says
Oppenheimer lifted their price objective on Savara from $8.00 to $9.00 and gave the company an "outperform" rating in a research note on Friday...
MarketBeat·13d ago
News Placeholder
Citizens Jmp Cuts Savara (NASDAQ:SVRA) Price Target to $10.00
Citizens Jmp dropped their price target on Savara from $11.00 to $10.00 and set a "market outperform" rating on the stock in a research note on Thursday...
MarketBeat·14d ago
News Placeholder
Savara (NASDAQ:SVRA) Posts Earnings Results, Misses Expectations By $0.01 EPS
Savara (NASDAQ:SVRA - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.14) earnings per share for the quarter, missing analysts' consensus estimates of...
MarketBeat·15d ago
News Placeholder
Savara Reports Third Quarter 2025 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2025...
Business Wire·16d ago

Latest SVRA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.